Robotic Telesurgery Across 7,000 Miles: Orlando to Angola
In what medical professionals are calling “a huge leap for health care,” a notable surgical procedure connected two continents in June 2025. Fernando da Silva, a prostate cancer patient in Angola, became the first patient in an FDA-approved clinical trial of transcontinental robotic telesurgery, with his surgeon operating from about 7,000 miles away in Orlando, Florida, on 14 June 2025.
A correction to the original version of this article: this was not the first transcontinental telesurgery. In 2001, surgeons in New York performed a robot-assisted gall bladder operation on a patient in Strasbourg, France (the “Lindbergh operation”). The 2025 case is better described as one of the longest-distance telesurgeries and the first patient in an FDA-approved transcontinental telesurgery trial. It was also not performed with a da Vinci system: MicroPort MedBot reports that the Toumai robotic system was used.
It was a significant demonstration, and it hints at how medical care might one day reach underserved populations, potentially improving surgical access in regions where specialist expertise is scarce, although that remains to be shown.
The Procedure
Da Silva was the first patient of a human clinical trial approved by the U.S. Food and Drug Administration to test transcontinental robotic telesurgery. The procedure, a prostatectomy to remove cancerous tissue, was performed by Dr Vipul Patel, medical director of the Global Robotic Institute at Orlando’s AdventHealth, using a robotic surgical system connected via a telecommunications link spanning two continents.
Orchestrating such a procedure is complex. “We’ve been working on this really for two years,” Dr Patel explained, “We travelled the globe, looking at the right technologies.” The meticulous preparation included establishing redundant safety protocols, with a fully qualified surgical team standing by in Angola ready to take over should any technical complications arise.
The aim was to test whether high-quality surgical care could transcend geographical boundaries. The procedure used a Toumai robotic surgical system, made by the Chinese company MicroPort MedBot, rather than the better-known da Vinci system, with its reach extended across oceans through high-speed telecommunications infrastructure.
The Technology Behind the Procedure
Robotic surgery systems more generally, exemplified by platforms like the da Vinci Surgical System, have transformed minimally invasive surgery since receiving FDA approval in 2000. In 2000, the da Vinci Surgical System became the first robotic surgical platform commercially available in the United States to be cleared by the FDA for use in general laparoscopic surgery.
These sophisticated systems allow surgeons to perform intricate procedures through small incisions using robotic arms controlled from a console that provides enhanced visualisation and tremor-free precision. The technology’s evolution has been remarkable: Since its inception in 1985, robotic surgery has evolved into a mainstream surgical approach that has become virtually synonymous with minimally invasive surgery and adopted across several specialties offering decreased patient morbidity and improved post-operative outcomes.
The transcontinental application required additional innovations in telecommunications technology, ensuring that the surgeon’s movements could be transmitted in real-time with minimal latency—a critical factor when precision is measured in millimetres and seconds can mean the difference between success and complication.
Addressing Global Surgical Inequality
The potential humanitarian implications extend beyond a single procedure. Africa faces a profound shortage of surgical specialists, with many patients unable to access life-saving procedures due to geographical and economic barriers. The Global Surgery 2030 initiative has highlighted these disparities, noting that surgical care remains inaccessible to billions worldwide.
“I think the humanitarian implications are enormous,” Dr Patel observed. “Internationally, obviously, there’s so many underserved areas of the world.” The technology could potentially bridge the gap between regions with abundant surgical expertise and those facing critical shortages, democratising access to specialised care.
Consider the current landscape: whilst developed nations boast sophisticated medical infrastructure and abundant specialist surgeons, vast regions of Africa, Asia, and Latin America struggle with basic surgical capacity. Organisations like the College of Surgeons of East, Central and Southern Africa (COSECSA) work tirelessly to build local surgical capacity, but the scale of need often outpaces training capabilities.
Implications for Rural and Emergency Medicine
The applications extend beyond international boundaries. Rural communities within developed nations often face similar challenges accessing specialist surgical care. Dr Patel envisions scenarios where “Emergency room physicians will have technology that can be remotely accessible to surgeons, maybe even in the ambulance, where people can get remote interventions if they can’t make it to the hospital.”
This could change emergency medicine, allowing specialist intervention to begin during transport to hospital, potentially saving lives in critical situations where every minute counts. Rural hospitals, often understaffed and lacking specialist expertise, could benefit from remote guidance during complex procedures or emergency situations.
The Operation Smile initiative and similar programmes have demonstrated the hunger for surgical capacity building in underserved regions. Telesurgery could support these efforts, allowing experienced surgeons to mentor local practitioners and perform complex procedures remotely when local expertise isn’t available.
Challenges and Considerations
Despite its promise, transcontinental telesurgery faces significant hurdles. Telecommunications infrastructure in many underserved regions remains inadequate for the high-bandwidth, low-latency connections required for real-time surgical control. The technology demands substantial investment in both equipment and training, potentially limiting its immediate accessibility.
Regulatory frameworks also present challenges. Each jurisdiction has distinct medical licensing requirements and liability frameworks. Cross-border telesurgery raises complex questions about medical responsibility, insurance coverage, and quality assurance that regulatory bodies worldwide must address.
Furthermore, the human element cannot be overlooked. Surgery remains as much art as science, relying on tactile feedback, situational awareness, and rapid decision-making that current technology may not fully replicate across vast distances. Dr Patel’s insistence on maintaining qualified surgical teams at the patient’s location acknowledges these limitations whilst prioritising patient safety above technological ambition.
The Future of Global Surgery
Dr Patel was expected to submit data from the procedure to the FDA for review as part of the trial. Success could pave the way for expanded clinical trials and eventual widespread adoption of transcontinental telesurgery protocols.
The technology’s evolution will likely focus on improving tactile feedback, reducing latency, and enhancing fail-safe mechanisms. Artificial intelligence integration could provide additional safety layers, monitoring procedures in real-time and alerting surgeons to potential complications before they become critical.
Training programmes will need to evolve to prepare surgeons for remote operations, whilst new specialisations may emerge focused specifically on telesurgical techniques. Medical schools and residency programmes may need to incorporate virtual reality training and remote surgical simulation into their curricula.
Economic and Ethical Implications
The economic implications are uncertain. Whilst initial setup costs are substantial, telesurgery might ultimately reduce healthcare costs by eliminating the need for patient travel, reducing hospital stays through minimally invasive techniques, and maximising the utilisation of specialist surgical expertise.
However, ethical questions remain. Will this technology exacerbate global health inequalities by concentrating surgical expertise in wealthy nations whilst underserved regions remain dependent on remote intervention? Or will it democratise access to care by making specialist expertise available regardless of geographical location?
The answer likely depends on how the technology is implemented and regulated. Programmes focused on building local capacity whilst providing remote support may prove more sustainable than systems that create permanent dependence on external expertise.
Looking Ahead
The successful completion of what was reported as the first telesurgery between the United States and Africa shows the potential for medicine to transcend traditional boundaries. A single patient is not proof that the approach is safe and effective in general; that is what the clinical trial is for.
The journey from concept to reality required about two years of planning, international collaboration, and regulatory approval. The next phase will determine whether this can be scaled to benefit the millions worldwide who currently lack access to essential surgical care.
As Dr Patel reflected on the historic procedure, his words encapsulate both the achievement and the promise it represents: “It was a small step for a surgeon, but it was huge leap for health care.” Whether this single procedure marks the beginning of a new era in global surgery will depend on the trial results.
As technology advances and global connectivity improves, remote surgery may become a practical option in more places.
We’d like to hear your questions or comments on today’s topic!
For more articles like this one, click here.
Thought for the day:
“The practice of peace and reconciliation is one of the most vital and artistic of human actions.”
Thich Nhat Hanh